Table 3.

Cytokine levels of CD subjects stratified by ASAS MRI positivity

Variable	ASAS MRI positive (N = 6, 18%)	ASAS MRI negative (N = 25, 82%)	p-value
Cytokine
Interleukin 2	4.7 ± 2.0	5.6 ± 7.8	0.79
Interleukin 4	3.5 ± 1.6	5.7 ± 4.6	0.33
Interleukin 5	3.7 ± 0.0	3.8 ± 0.1	0.25
Interleukin 6	6.2 ± 7.2	5.1 ± 6.9	0.71
Interleukin 9	2.4 ± 1.5	1.9 ± 0.9	0.29
Interleukin 10	31.0 ± 59.3	6.5 ± 1.8	0.36
Interleukin 13	8.9 ± 6.3	8.9 ± 4.4	0.93
Interleukin 12–23	214.0 ± 159.5	259.1 ± 227.7	0.65
Interleukin 17A	25.3 ± 13.1	21.1 ± 10.5	0.40
Interleukin 17F	4.8 ± 2.2	3.8 ± 3.5	0.49
Interleukin 21	19.8 ± 36.2	40.0 ± 43.2	0.30
Interleukin 22	15.2 ± 7.1	16.7 ± 11.2	0.75
Interferon-γ	75.7 ± 31.0	79.0 ± 28.8	0.80
TNF-α	19.5 ± 15.2	35.4 ± 94.1	0.68

ASAS=Assessment of SpondyloArthritis international Society, CD=Crohn’s disease, TNF= tumor necrosis factor